These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M; Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521 [TBL] [Abstract][Full Text] [Related]
9. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies. Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063 [TBL] [Abstract][Full Text] [Related]
10. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review. Lund M; Trads M; Njor SH; Erichsen R; Andersen B JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154 [TBL] [Abstract][Full Text] [Related]
11. Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients. Kim TJ; Kim ER; Hong SN; Kim YH; Baek SY; Ahn S; Chang DK Gastrointest Endosc; 2018 Mar; 87(3):809-817.e1. PubMed ID: 28987544 [TBL] [Abstract][Full Text] [Related]
12. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study. Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015 [TBL] [Abstract][Full Text] [Related]
13. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry. Anderson JC; Butterly LF; Goodrich M; Robinson CM; Weiss JE Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1308-12. PubMed ID: 23660415 [TBL] [Abstract][Full Text] [Related]
14. Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy. Wadhwa V; Jobanputra Y; Al Taii H; Thota PN; Lopez R; Gurudu SR; Sanaka MR Surg Endosc; 2020 Jan; 34(1):325-331. PubMed ID: 30927122 [TBL] [Abstract][Full Text] [Related]
15. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps. Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1518-1527.e7. PubMed ID: 38325601 [TBL] [Abstract][Full Text] [Related]
16. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study. Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754 [TBL] [Abstract][Full Text] [Related]
17. Comparison of adenoma detection rate and proximal serrated polyp detection rate and their effect on post-colonoscopy colorectal cancer mortality in screening patients. Zessner-Spitzenberg J; Waldmann E; Jiricka L; Rockenbauer LM; Hinterberger A; Cook J; Asaturi A; Szymanska A; Majcher B; Trauner M; Ferlitsch M Endoscopy; 2023 May; 55(5):434-441. PubMed ID: 36482285 [TBL] [Abstract][Full Text] [Related]
18. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study. Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114 [TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690 [TBL] [Abstract][Full Text] [Related]
20. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs. Austin GL; Fennimore B; Ahnen DJ Am J Gastroenterol; 2013 Mar; 108(3):296-301. PubMed ID: 23208273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]